EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

Cost‐Effectiveness of Personalised Nutrition in Adults With Overweight and Obesity: PREVENTOMICS Studies in Poland and the UK

Milanne Maria Johanna Galekop iD, Philip C Calder, Ella J Baker, Joanna Góralska, Urszula Raźny, Malgorzata Malczewska-Malec, Carin A Uyl-de Groot, William Ken Redekop

Journal of Human Nutrition and Dietetics · 2025

DOI: 10.1111/jhn.70071 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Human Nutrition and Dietetics, 2025. Verfasst von Milanne Maria Johanna Galekop und 7 weiteren Autor:innen. Beteiligte Einrichtung: Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Obesity, Overweight, Precision Medicine, Cost-Effectiveness Analysis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was funded by the European Union's Horizon 2020 research and innovation program (Grant 818318)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We assessed the cost‐effectiveness of personalised nutrition in adults with overweight/obesity in Poland and the United Kingdom (UK) using the results of two randomised controlled trials (RCTs).

Methods

The 4‐month RCTs compared three interventions: personalised plan (PP) plus behavioural change (PP+B), PP only, and a control. Outcomes included body mass index (BMI), health‐related quality of life (EQ‐5D‐5L), quality‐adjusted life years (QALYs), and costs (2020 British pounds). A Markov model estimated lifetime cost‐effectiveness. Different sensitivity analyses were performed.

Results

Participants were randomised to PP+B, PP, and control groups in Poland ( n = 89, n = 88, n = 88) and the UK ( n = 20, n = 19, n = 15). Comparing BMI reductions of PP+B and PP with control in both countries showed no significant differences, but wide confidence intervals (CIs) were observed (e.g., PP+B vs. control—Poland: −0.20, 95% CI: −0.86, 0.45 kg/m 2 ; UK: −0.80, 95% CI: −1.60, 0.00 kg/m 2 ). Lifetime analysis suggested potential cost‐effectiveness for PP+B in Poland (£20,404 per QALY gain), and for PP+B (£13,006 per QALY) and PP (£12,222 per QALY) in the UK, since these figures were lower than the willingness‐to‐pay thresholds (£34,000 in Poland and £20,000 in the UK). PP in Poland was dominated by control, but sensitivity analyses suggested potential cost‐effectiveness.

Conclusions

The PREVENTOMICS interventions may offer a cost‐effective approach to reduce weight and avoid its related complications in both countries. Future studies should be larger and/or longer to reduce uncertainty about effectiveness. Clinical Trial Registration Numbers: Poland ISRCTN51509551 and the UK ISRCTN46063864.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityOverweightPrecision MedicineCost-Effectiveness AnalysisAdultFemaleHumansMaleMiddle AgedBody Mass IndexPolandQuality of LifeQuality-Adjusted Life YearsUnited Kingdom

Stichwörter der Autor:innen

cost‐effectiveness analysisobesityoverweightpersonalised nutrition

Autor:innen und Institutionen

  • Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
  • NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust and University of Southampton, Southampton, UK.
  • Department of Clinical Biochemistry, Genetics and Nutrigenomics, Chair in Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland.

ORCID-Profile: Milanne Maria Johanna Galekop

Förderung

  • This study was funded by the European Union's Horizon 2020 research and innovation program (Grant 818318).

Zitieren

APA

Galekop, M. M. J., Calder, P. C., Baker, E. J., Góralska, J., Raźny, U., Malczewska-Malec, M., Uyl-de Groot, C. A., & Redekop, W. K. (2025). Cost‐Effectiveness of Personalised Nutrition in Adults With Overweight and Obesity: PREVENTOMICS Studies in Poland and the UK. Journal of Human Nutrition and Dietetics. https://doi.org/10.1111/jhn.70071

Vancouver

Galekop MMJ, Calder PC, Baker EJ, Góralska J, Raźny U, Malczewska-Malec M, et al. Cost‐Effectiveness of Personalised Nutrition in Adults With Overweight and Obesity: PREVENTOMICS Studies in Poland and the UK. Journal of Human Nutrition and Dietetics. 2025. doi:10.1111/jhn.70071

BibTeX
@article{Galekop2025,
  author = {Galekop, Milanne Maria Johanna and Calder, Philip C and Baker, Ella J and Góralska, Joanna and Raźny, Urszula and Malczewska-Malec, Malgorzata and Uyl-de Groot, Carin A and Redekop, William Ken},
  title = {Cost‐Effectiveness of Personalised Nutrition in Adults With Overweight and Obesity: PREVENTOMICS Studies in Poland and the UK},
  journal = {Journal of Human Nutrition and Dietetics},
  year = {2025},
  doi = {10.1111/jhn.70071}
}
Kostenlos starten →